Source comparison
CJC-1295 vs Other Sleep-Affecting Peptides: Mechanism Comparison
CJC-1295 DAC GHRH receptor agonist. Amplifies endogenous GH pulses during SWS Slow-wave sleep (Stage N3) duration +15–25% 2–3 hours pre-sleep for circadian alignment GHRH receptor (anterior pituitary somatotrophs) Best for recovery optimization in individuals
This comparison does not assign a generated winner or score.
- CJC-1295 DAC
- GHRH receptor agonist. Amplifies endogenous GH pulses during SWS
- Slow-wave sleep (Stage N3) duration +15–25%
- 2–3 hours pre-sleep for circadian alignment
- GHRH receptor (anterior pituitary somatotrophs)
- Best for recovery optimization in individuals with intact sleep architecture. Does not address insomnia or fragmentation
- DSIP (Delta Sleep-Inducing Peptide)
- Proposed GABAergic modulation + calcium channel effects (mechanism contested)
- Sleep latency reduction, possible SWS increase
- 30–60 minutes pre-sleep
- Unknown. No confirmed receptor identified
- Evidence is largely anecdotal; no FDA-approved trials confirm sleep induction in humans
- Ipamorelin + CJC-1295 (combined)
- Dual ghrelin receptor + GHRH receptor agonism
- SWS duration, GH pulse frequency and amplitude
- 30–60 minutes pre-sleep (no-DAC variant)
- Ghrelin receptor + GHRH receptor
- Synergistic GH release. Greater SWS enhancement than CJC-1295 alone, but also higher appetite stimulation
- MK-677 (Ibutamoren)
- Ghrelin receptor agonist. Oral bioavailability, 24-hour half-life
- SWS duration +20–50%, REM sleep slight reduction
- Daily oral dosing (evening preferred)
- Ghrelin receptor (growth hormone secretagogue receptor 1a)
- Convenient oral administration, but chronic daily dosing may desensitize GH response over 6–12 months
- Selank
- Anxiolytic peptide. Modulates GABA and serotonin pathways
- Sleep latency, anxiety-related wakefulness
- 2–4 hours pre-sleep (intranasal)
- GABAergic system (indirect)
- Addresses sleep onset difficulty via anxiolysis. Does not affect SWS architecture or GH pulsatility
- CJC-1295 sits in a specific niche: it's not a sleep-inducing peptide (like DSIP is claimed to be), and it's not an anxiolytic that reduces pre-sleep arousal (like Selank). It's a recovery peptide that works by synchronizing with the body's natural overnight GH surge. If your goal is falling asleep faster, other compounds are more appropriate. If your goal is maximizing tissue repair, protein synthesis, and cognitive consolidation during sleep you're already achieving, CJC-1295's GH amplification is mechanistically on-target.
- The combination of CJC-1295 + Ipamorelin (a ghrelin receptor agonist) produces additive effects. Ipamorelin increases GH pulse frequency while CJC-1295 increases pulse amplitude and duration. Clinical data from anti-aging research shows this combination elevates nocturnal GH secretion by 2–3× baseline, with corresponding increases in SWS duration, but also significantly increases ghrelin-mediated hunger signaling upon waking. That trade-off. Deeper sleep vs morning appetite surge. Is why the combination is more common in bodybuilding recovery protocols than in pure sleep optimization.